UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma

Molecular therapy, 2017-09, Vol.25 (9), p.2214-2224

2017

Volltextzugriff (PDF)

In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin’s Lymphomas

Molecular therapy, 2018-12, Vol.26 (12), p.2727-2737

2018

Volltextzugriff (PDF)

Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma

Blood, 2011-12, Vol.118 (23), p.6050-6056

2011

Volltextzugriff (PDF)

Manufacturing mesenchymal stromal cells for phase I clinical trials

Cytotherapy (Oxford, England), 2013-04, Vol.15 (4), p.416-422

2013

Volltextzugriff (PDF)

T Cell-Activating Mesenchymal Stem Cells as a Biotherapeutic for HCC

Molecular therapy. Oncolytics, 2017-09, Vol.6 (C), p.69-79

2017

Volltextzugriff (PDF)

Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes

The Journal of clinical investigation, 2017-09, Vol.127 (9), p.3462-3471

2017

Volltextzugriff (PDF)

Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

Journal of clinical oncology, 2015-05, Vol.33 (15), p.1688-1696

2015

Volltextzugriff (PDF)

Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma

Blood, 2003-03, Vol.101 (5), p.1718-1726

2003

Volltextzugriff (PDF)

Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation

Blood, 2006-02, Vol.107 (4), p.1332-1341

2006

Volltextzugriff (PDF)

Clinical responses with T lymphocytes targeting malignancy-associated κ light chains

The Journal of clinical investigation, 2016-07, Vol.126 (7), p.2588-2596

2016

Volltextzugriff (PDF)

Phase I trial of vaccination with autologous neuroblastoma tumor cells genetically modified to secrete IL-2 and lymphotactin

Journal of immunotherapy, 2007-02, Vol.30 (2), p.227-233

2007

Volltextzugriff (PDF)

CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients

The Journal of clinical investigation, 2011-05, Vol.121 (5), p.1822-1826

2011

Volltextzugriff (PDF)

Phase 1 clinical trial of adoptive immunotherapy using “off-the-shelf” activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia

Cytotherapy (Oxford, England), 2017-10, Vol.19 (10), p.1225-1232

2017

Volltextzugriff (PDF)

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

Nature medicine, 2008-11, Vol.14 (11), p.1264-1270

2008

Volltextzugriff (PDF)

Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas

Blood, 2024-03, Vol.143 (13), p.1231-1241

2024

Volltextzugriff (PDF)

A Phase 2 Study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2024-04, Vol.118 (5), p.1531-1540

2024

Volltextzugriff (PDF)

Stability of adenoviral vectors used in gene therapy

Cytotherapy (Oxford, England), 2020-05, Vol.22 (5), p.S185-S185

2020

Volltextzugriff (PDF)

Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors

Journal of clinical oncology, 2024-08, Vol.42 (23), p.2769-2779

2024

Volltextzugriff (PDF)

A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer

Clinical cancer research, 2022-10, Vol.28 (20), p.4392-4401

2022

Volltextzugriff (PDF)

Preliminary Report on the Safety and Tolerability of Bone marrow-derived Allogeneic Mesenchymal Stem Cells infused intravenously in Parkinson’s disease Patients (S16.008)

Neurology, 2019-04, Vol.92 (15_supplement)

2019

Volltextzugriff (PDF)

645. T-Cell Activating Mesenchymal Stem Cells as a Biotherapeutic for HCC

Molecular therapy, 2016-05, Vol.24, p.S255-S256

2016

Volltextzugriff (PDF)

Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications

Cytotherapy (Oxford, England), 2012-10, Vol.14 (9), p.1131-1143

2012

Volltextzugriff (PDF)

Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the Quantum Cell Expansion System

Cytotherapy (Oxford, England), 2014-08, Vol.16 (8), p.1048-1058

2014

Volltextzugriff (PDF)

Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes

Human gene therapy, 2001-04, Vol.12 (6), p.659-670

2001

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(49)
Buchkapitel
(1)

Sprache

Englisch
(44)
Chinesisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(29)
Humans
(21)
Medicine, Research & Experimental
(18)
Research & Experimental Medicine
(18)
Female
(14)
Hematology
(13)
Male
(13)
Biotechnology & Applied Microbiology
(11)
Immunotherapy
(10)
Oncology
(10)
Child
(9)
Cell Biology
(8)
Treatment Outcome
(8)
Adolescent
(7)
Antigens
(7)
Lymphocytes
(7)
T-Lymphocytes - Immunology
(7)
Cell & Tissue Engineering
(6)
Child, Preschool
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma

In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin’s Lymphomas

Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma

Manufacturing mesenchymal stromal cells for phase I clinical trials

T Cell-Activating Mesenchymal Stem Cells as a Biotherapeutic for HCC

Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes

Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma

Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation

Clinical responses with T lymphocytes targeting malignancy-associated κ light chains

Phase I trial of vaccination with autologous neuroblastoma tumor cells genetically modified to secrete IL-2 and lymphotactin

CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients

Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study

Phase 1 clinical trial of adoptive immunotherapy using “off-the-shelf” activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas

A Phase 2 Study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung Cancer

Stability of adenoviral vectors used in gene therapy

Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors

A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer

Preliminary Report on the Safety and Tolerability of Bone marrow-derived Allogeneic Mesenchymal Stem Cells infused intravenously in Parkinson’s disease Patients (S16.008)

645. T-Cell Activating Mesenchymal Stem Cells as a Biotherapeutic for HCC

Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications

Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the Quantum Cell Expansion System

Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes

Suchergebnisse filtern